Workflow
多瑞医药(301075.SZ)：拟成立全资子公司西藏瑞升祥医药有限公司
DUO RUI PHARMADUO RUI PHARMA(SZ:301075) Ge Long Hui A P P·2025-11-07 08:23

Core Viewpoint - Duori Pharmaceutical (301075.SZ) has established a wholly-owned subsidiary, Tibet Ruishengxiang Pharmaceutical Co., Ltd., to optimize its headquarters management functions and align with its long-term development strategy and shareholder interests [1] Group 1 - The new subsidiary will engage in the distribution of pharmaceuticals and medical devices [1] - The establishment of the subsidiary is part of the company's strategic development needs [1] - This move is aimed at enhancing the management efficiency of the company's headquarters [1]